Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Home Depot Inc (HD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Home Depot Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $25.99 (market cap $4.49B), while Home Depot Inc trades at $336.48 (market cap $344.21B). The key difference: Home Depot Inc is far larger — about 76.7× ACADIA Pharmaceuticals Inc.'s market cap, and Home Depot Inc pays a 2.7% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | HD | |
|---|---|---|
Market Cap | $4.49B | $344.21B |
Sector | Health | Consumer Cyclical |
52-Week High | $28.06 | $423.42 |
52-Week Low | $20.06 | $297.51 |
Enterprise Value | $3.69B | $405.77B |
Dividend Yield | — | 2.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACAD trades at $26.20, up 0.89% today, with strong analyst consensus (70% buy ratings) and a $33.67 price target. Recent CHMP recommendation for Daybue in Europe (Business Wire, June 26, 2026) drove positive sentiment. The stock shows bullish technical signals with moving averages supporting upside, though RSI levels indicate overbought conditions. Fundamentally, revenue grew to $1.07B in 2025 with a robust net income margin of 34.3%, though Q1 2026 earnings missed expectations.
Outlook remains positive given commercial execution and pipeline catalysts like remlifanserin data, but risks include earnings volatility and regulatory dependencies. The stock offers growth potential in neuropsychiatry markets, balanced by execution risks in clinical trials and competitive pressures.
Home Depot (HD) trades at $336.34, down 4.08% over 24 hours, with a bullish technical signal from moving averages but neutral oscillators. The company reported mixed quarterly earnings, beating in Q4 2025 and Q1 2026 but missing in Q3 2025. Revenue for 2025 reached $159.51 billion with a net income margin of 8.41%, while cash flow from operations was strong at $19.81 billion. Recent news highlights institutional activity and market reactions to housing sector trends.
The outlook remains supported by analyst consensus with a $370.59 price target and 59% buy ratings, though risks include weakening big-ticket demand and margin pressures from investments. Long-term growth hinges on Pro customer segment strength and housing market tailwinds, but rising mortgage rates pose headwinds for near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →
